---
title: Clario vs ICON plc
slug_a: clario
slug_b: iconplc
site: cro
review_signal_gate: closed
canonical_path: /compare/clario/iconplc
generated_by: BioBM Editorial AI
---

# Clario vs ICON plc

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clario (clario) is listed for cro. Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Services: 16. Modalities: 4. Indications: 12. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (16).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

ICON plc (iconplc) is listed for cro. ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies.

Services: 29. Modalities: 6. Indications: 9. Locations: 52. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (52).

Review summary: Review summary withheld until site-level review gate opens.